11.07.2015 Views

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCTable 5.2. C<strong>on</strong>td.DrugRecommended regularm<strong>on</strong>itor<strong>in</strong>gCommentsIs<strong>on</strong>iazid- M<strong>on</strong>thly cl<strong>in</strong>ical- Vitam<strong>in</strong> B 6(pyridox<strong>in</strong>e) 10mg/day may decrease peripheral neuritisevaluati<strong>on</strong><strong>and</strong> CNS effects <strong>and</strong> should be used <strong>in</strong> patients who are abus<strong>in</strong>g- Liver functi<strong>on</strong> tests 3 alcohol, pregnant, breastfeed<strong>in</strong>g <strong>in</strong>fants <strong>on</strong> is<strong>on</strong>iazid, malnourished,or who have HIV <strong>in</strong>fecti<strong>on</strong>, cancer, chr<strong>on</strong>ic renal or liver disease,diabetes, or pre-exist<strong>in</strong>g peripheral neuropathy- Alum<strong>in</strong>ium-c<strong>on</strong>ta<strong>in</strong><strong>in</strong>g antacids reduce absorpti<strong>on</strong>- Drug <strong>in</strong>teracti<strong>on</strong>s with several agentsRifampic<strong>in</strong>Pyraz<strong>in</strong>amideEthambutolStreptomyc<strong>in</strong>- M<strong>on</strong>thly cl<strong>in</strong>icalevaluati<strong>on</strong>- Complete blood cellcount <strong>in</strong>clud<strong>in</strong>g platelets<strong>and</strong> liver functi<strong>on</strong> testsas <strong>in</strong>dicated 3- M<strong>on</strong>thly cl<strong>in</strong>icalevaluati<strong>on</strong>- Liver functi<strong>on</strong> tests as<strong>in</strong>dicated 3- M<strong>on</strong>thly cl<strong>in</strong>icalevaluati<strong>on</strong>- Check colour visi<strong>on</strong> <strong>and</strong>visual acuity m<strong>on</strong>thly- M<strong>on</strong>thly cl<strong>in</strong>icalevaluati<strong>on</strong>- Audiometry, renalfuncti<strong>on</strong>, electrolytes,<strong>in</strong>clud<strong>in</strong>g magnesium- Orange discolourati<strong>on</strong> may occur <strong>in</strong> c<strong>on</strong>tact lenses <strong>and</strong> bodysecreti<strong>on</strong>s such as tears <strong>and</strong> ur<strong>in</strong>e- Patients receiv<strong>in</strong>g methad<strong>on</strong>e will need <strong>the</strong>ir methad<strong>on</strong>e dosage<strong>in</strong>creased, by an average <strong>of</strong> 50%, to avoid opioid withdrawal- Interacti<strong>on</strong> with many drugs leads to decreased levels <strong>of</strong> <strong>the</strong> coadm<strong>in</strong>istereddrug- May make glucose c<strong>on</strong>trol more difficult <strong>in</strong> people with diabetes.- C<strong>on</strong>tra<strong>in</strong>dicated for patients tak<strong>in</strong>g most PIs <strong>and</strong> NNRTIs- Patients should be advised to use barrier c<strong>on</strong>traceptives while <strong>on</strong>rifampic<strong>in</strong>- May complicate management <strong>of</strong> diabetes mellitus- Hyperuricaemia can be used as <strong>in</strong>dicator <strong>of</strong> compliance- Treat <strong>in</strong>creased uric acid <strong>on</strong>ly if symptomatic- Allopur<strong>in</strong>ol <strong>in</strong>creases level <strong>of</strong> pyraz<strong>in</strong>amide by <strong>in</strong>hibit<strong>in</strong>g xanth<strong>in</strong>eoxidase result<strong>in</strong>g <strong>in</strong> failure <strong>of</strong> allopur<strong>in</strong>ol to lower serum uric acid- Optic neuritis may be unilateral; check each eye separately. Ifpossible avoid <strong>in</strong> children too young to undergo visi<strong>on</strong> test<strong>in</strong>g.- If patient develops visual compla<strong>in</strong>ts, refer for promptophthalmologic evaluati<strong>on</strong>. May need to disc<strong>on</strong>t<strong>in</strong>ue ethambutolwhile await<strong>in</strong>g evaluati<strong>on</strong>.- Ultrasound <strong>and</strong> warm compresses to <strong>in</strong>jecti<strong>on</strong> site may reduce pa<strong>in</strong><strong>and</strong> <strong>in</strong>durati<strong>on</strong>1World Health Organizati<strong>on</strong> (WHO), Internati<strong>on</strong>al Uni<strong>on</strong> aga<strong>in</strong>st TB <strong>and</strong> Lung Disease (IUATLD), <strong>and</strong> British Thoracic Society (BTS)recommend 5mg/kg <strong>in</strong> children; Centers for Disease C<strong>on</strong>trol <strong>and</strong> Preventi<strong>on</strong> (CDC), American Thoracic Society (ATS), InfectiousDisease Society <strong>of</strong> America (IDSA) <strong>and</strong> <strong>the</strong> American Academy <strong>of</strong> Paediatrics (AAP) recommend 10-20mg/kg2WHO, IUATLD, <strong>and</strong> BTS recommend 10mg/kg <strong>in</strong> children; CDC/ATS <strong>and</strong> <strong>the</strong> AAP recommend 10-20mg/kg3Liver functi<strong>on</strong> tests are <strong>in</strong>dicated if basel<strong>in</strong>e is abnormal or patient has risk factors for toxicityReproduced with k<strong>in</strong>d permissi<strong>on</strong> from <strong>Tuberculosis</strong>, Cl<strong>in</strong>ical Policies <strong>and</strong> Protocols. New York City Department <strong>of</strong> Health <strong>and</strong> MentalHygiene (2008). Available at www.nyc.gov/html/doh/downloads/pdf/tb/tb-protocol.pdfRecommendati<strong>on</strong>:To enhance compliance <strong>and</strong> to m<strong>in</strong>imise potential problems from <strong>the</strong> development <strong>of</strong> drugresistance, it is str<strong>on</strong>gly recommended that <strong>on</strong>ly comb<strong>in</strong>ati<strong>on</strong> tablets should be used.Syrup/tablet dosage should be rounded up or down to facilitate <strong>the</strong> prescripti<strong>on</strong> <strong>of</strong> easily given volumes/tablets. All cases <strong>of</strong> TB placed <strong>on</strong> <strong>the</strong> above regimens for active disease should be notified to <strong>the</strong> localpublic health physicians. In additi<strong>on</strong>, <strong>the</strong> committee recommends rout<strong>in</strong>e audit <strong>of</strong> both <strong>in</strong>patient <strong>and</strong>outpatient care <strong>of</strong> TB.Care should be taken <strong>in</strong> writ<strong>in</strong>g prescripti<strong>on</strong>s so that rifad<strong>in</strong> (c<strong>on</strong>ta<strong>in</strong>s rifampic<strong>in</strong> <strong>on</strong>ly) is not c<strong>on</strong>fused withrif<strong>in</strong>ah (c<strong>on</strong>ta<strong>in</strong>s rifampic<strong>in</strong> <strong>and</strong> is<strong>on</strong>iazid) <strong>and</strong> rifater (c<strong>on</strong>ta<strong>in</strong>s rifampic<strong>in</strong>, is<strong>on</strong>iazid <strong>and</strong> pyraz<strong>in</strong>amide).-68-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!